Mayo Clinic Researchers Stop Neuromyelitis Optica Attacks with New Therapy

Mayo Clinic researchers have identified a new therapy for patients with neuromyelitis optica (NMO) that appears to stop inflammation of the eye nerves and spinal cord. NMO is a debilitating central nervous system disorder that is often misdiagnosed as multiple sclerosis (MS). In the study, patients with severe symptoms of the disease, also known as NMO, were given eculizumab, a drug typically used to treat blood disorders.

While not a cure, the therapy Mayo Clinic researchers used in the study to halt attacks could potentially lead to longer attack-free periods for the thousands of NMO patients worldwide.



Find out more about Neuromyelitis Optica (NMO) Spectrum Disorders and available tests at Mayo Medical Laboratories by clicking on the link below.


Mayo Medical Laboratories

This post was authored by the Marketing Team at Mayo Medical Laboratories.